Financials
Financial year 2025
EndoCard from Jabbeke, company number BE0697720802, closed financial year 2025 with a result of € 615,287 after tax. For that financial year EndoCard recorded a gross margin of € 936,150 and equity of € 633,887. Compared with financial year 2024, the result moved from € 645,661 to € 615,287. The company is profitable. The company holds a healthy buffer. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on October 24, 2025.
€ 633,887
▼ 5% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 615,287
▼ 5% vs 2024
Profit after tax over the fiscal year.
€ 536,829
▲ 48% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 647,646 paid out
More than the year’s profit went to the shareholders; reserves fell.
People and assets in 2025
€ 84,142
▲ 260% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 1.2 million
▼ 7% vs 2024
€ 93,697 is repaid this year. At this pace the long-term loan is gone in ≈ 13 years.
€ 2,206
▼ 51% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 57,578
▲ € 45,944 vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 558,437 | € 583,744 | € 949,380 | € 936,150 | ▼ 1% |
| Profit after taxes | € 424,035 | € 246,985 | € 645,661 | € 615,287 | ▼ 5% |
| Equity | € 18,600 | € 265,585 | € 666,246 | € 633,887 | ▼ 5% |
| Total debts | € 468,537 | € 1,722,663 | € 1,655,907 | € 1,690,079 | ▲ 2% |
| Cash | € 220,921 | € 190,491 | € 363,040 | € 536,829 | ▲ 48% |
| Land & buildings | - | € 1,491,264 | € 1,437,688 | € 1,384,112 | ▼ 4% |
| Retained profit | € 0 | € 246,985 | € 647,646 | € 615,287 | ▼ 5% |
| Dividend | € 1,238,872 | € 0 | € 245,000 | € 647,646 | ▲ 164% |
| Bank debt | € 0 | € 1,417,936 | € 1,327,081 | € 1,234,816 | ▼ 7% |
| Balance sheet total | € 487,137 | € 1,988,248 | € 2,322,152 | € 2,323,966 |
Key figures of EndoCard, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 October 2026.
What happened to EndoCard?
What happened at EndoCard in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 615,287 (▼ 5% vs 2024). Source: NBB ↗
- New establishment in Brugge. KBO
- New establishment in Kortrijk. KBO
- Start of the company according to the CBE. KBO
- Nick Hiltrop became a director. NBB
- Jo Hoste became a director. NBB
In short
From € 424,035 profit in 2022 to € 615,287 profit in 2025.
Paid € 623,766 in corporate taxes since 2022.
Best year ever: 2024, with € 645,661 profit.
Paid out € 2.1 million in dividends to the owners in total.
A new publication or filing at EndoCard? We notify you, reason included.
Follow EndoCardDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind EndoCard are Nick Hiltrop and Jo Hoste.
Directors
According to the 2025 annual accounts
Nick Hiltrop
Director
since 2018
Jo Hoste
Director
since 2018
Establishments
Establishment units
Physical locations of this company
Nieuwenhovedreef 26
8490 Jabbeke
Sint-Lucaslaan 29
8310 Brugge
Active since 7 June 2018
President Kennedylaan(Kor) 4
8500 Kortrijk
Active since 7 June 2018
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0697.720.802
- VAT number
- BE 0697.720.802
- Registered office
- Nieuwenhovedreef 26, 8490 Jabbeke
- Names & denominations
- EndoCard
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 7 June 2018
- Peppol
- Active · Active since 24 Nov 2024